i think you are closer to the mark than many others may think. I'm not fearful of any developments that may emerge in this area. My speculation (and this is all it is) is that at some point sooner rather than later, ahz will find a partner for Admedus immunotherapies and that it will be subsequently split from ahz as we know it. in this situation I would expect AHZ shareholders to receive shares in the new company.
imo this possibility was set up a couple of years ago....all i want is to be able to share in the ride..imo, there is no way ahz can afford to take HSV and HPV forward by itself...
as for price...who knows, i really have no idea, but for me it would have to be many many multiples of its existing MC....not good to give potential suitors any guidance imo
i have no doubt that WP will ensure maximum returns for shareholders in the near term irrespective of what happens
i think you are closer to the mark than many others may think....
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$10.21 |
Change
0.010(0.10%) |
Mkt cap ! $215.8M | |||
| Open | High | Low | Value | Volume |
| $10.50 | $10.50 | $10.06 | $60.58K | 5.907K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 3223 | $10.20 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $10.49 | 94 | 1 |
View Market Depth
| Last trade - 16.10pm 04/11/2024 (20 minute delay) ? |
| AVR (ASX) Chart |